A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

11K views

⸱

DOI:

10.3791/52351

⸱

January 10th, 2015

 ,  , 

In This Article

Summary

Using optimized human peripheral blood mononuclear cell (PBMC) ex vivo assays, we showed that a combustible tobacco product preparation markedly suppresses receptor-mediated intracellularly secreted cytokines and cytolytic ability of effector PBMCs. These rapid assays may be useful in product evaluation and understanding the potential long-term effects of tobacco exposure.

Abstract

Among other pathophysiological changes, chronic exposure to cigarette smoke causes inflammation and immune suppression, which have been linked to increased susceptibility of smokers to microbial infections and tumor incidence. Ex vivo suppression of receptor-mediated immune responses in human peripheral blood mononuclear cells (PBMCs) treated with smoke constituents is an attractive approach to study mechanisms and evaluate the likely long-term effects of exposure to tobacco products. Here, we optimized methods to perform ex vivo assays using PBMCs stimulated by bacterial lipopolysaccharide, a Toll-like receptor-4 ligand. The effects of whole smoke-conditioned medium (WS-CM), a combustible tobacco product preparation (TPP), and nicotine were investigated on cytokine secretion and target cell killing by PBMCs in the ex vivo assays. We show that secreted cytokines IFN-γ, TNF, IL-10, IL-6, and IL-8 and intracellular cytokines IFN-γ, TNF-α, and MIP-1α were suppressed in WS-CM-exposed PBMCs. The cytolytic function of effector PBMCs, as determined by a K562 target cell killing assay was also reduced by exposure to WS-CM; nicotine was minimally effective in these assays. In summary, we present a set of improved assays to evaluate the effects of TPPs in ex vivo assays, and these methods could be readily adapted for testing other products of interest.

Introduction

A substantial body of knowledge points to the adverse health effects of chronic cigarette smoking, including cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD) and cancer1,2. Chronic cigarette smoking has been known to cause inflammation and immune suppression, and these alterations are reported to contribute to increased risk of microbial infection and cancer in smokers3. In vitro and ex vivo techniques are useful in elucidating the molecular basis of the pathophysiological effects of cigarette smoke4-9 (Table 1) and are recognized as important tools for guiding the e....

Access restricted. Please log in or start a trial to view this content.

Protocol

NOTE: Written Informed consent to do this study was obtained at a local clinical research unit under IRB approval, per Good Clinical Practices. Processing of blood, isolation of PBMCs and other cell culture experiments are performed under sterile conditions, using microbiologically sterile supplies and reagents.

1. WS-CM Preparation

  1. Generate WS-CM as previously described12.
    1. Prepare WS-CM by passing smoke from four 3R4F reference cigarettes through Roswell Park Memorial Institute (RPMI) 1640 medium without phenol red using the following smoking regimen: 35-60-2, puff volume in ml, puff interval in sec, and ....

Access restricted. Please log in or start a trial to view this content.

Results

The results were presented as mean ± standard error of the mean (four donor samples). The student’s t-test between treated and untreated control samples was performed using Excel software as well as t-test comparisons for all treatments with their corresponding controls. The statistical significance was indicated by: *, P < 0.05; **, P < 0.005; ***, P < 0.0005.

To measure the effect of exposure to WS-CM and nicotine, PBMCs were treated with different concentrations of WS-CM and nicoti.......

Access restricted. Please log in or start a trial to view this content.

Discussion

We and others have previously demonstrated that treatment of PBMCs with TPPs suppresses several responses, including expression and secretion of cytokines and functional measures such as target cell killing14. The experimental methods described in the previous work require longer incubation periods and were modest in magnitude14. Given the potential applications of this attractive ex vivo model for basic and applied research, we investigated whether any of the assay parameters in these mult.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that there are no conflicts of interest.

Acknowledgements

This work is funded by R.J. Reynolds Tobacco Company (RJRT) under a collaborative research agreement with Wake Forest University School of Medicine. G.L. Prasad is a full time employee of RJRT.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
12 x 75 mm tubesBD Falcon352058
15 ml conical tubesCorning430790
2 ml microtubesAxygenMCT-150-C-S
3R4F reference cigarettesUniv. of Kentucky, College of Agriculture3R4F
50 ml conical tubesCorning430828
500 ml bottleCorning430282
7AADBD Pharmingen559925
96-well flat bottom plateTermo Nunc439454
96-well round bottom platesBD Falcon353077
Cell culture hoodThermo Scientific1300 Series A2
CentrifugeEppendorf58110R
CFSEMolecular Probes Life TechnologiesC34554
Cluster tubesCorning4401Harmful if swallowed, carcinogen
Cytofix/Cytoperm (Permwash)BD Biosciences555028Flammable
DMSO (dimethyl sulfoxide )Sigma-AldrichD8418
DPBSLonza17-512F
FBSSigma-AldrichF2442
FCAP ArrayBD Biosciences652099Software analyzes CBA data
Filter unitNalgene156-4020
Flow cytometerBD BiosciencesFACS Canto II8 colors, at Ex 405 and Em 785.
Flow cytometerBD BiosciencesFACS Calibur4 colors at Ex 495 and Em 785.
Flow cytometry analysis softwareTree StarFlowJo
Freezing containerNalgene5100-0001Contains DMSO, irritant
GogliPlugBD Biosciences555029Carcinogen, irritant, corrosive
H2SO4Sigma-Aldrich339741
Human Inflammatory Cytokine KitBD Biosciences551811
IFN-γ V-500 AntibodyBD Horizon561980skin sensitizer
IL-8 ELISA KitR and D SystemsDY208
Isolation bufferIsolymph, CTL Scientific Corp.1114868Flammable liquid, irritant
Isopropyl alcoholSigma-AldrichW292907
L-GlutamineGibco Life Technologies25030-081
LPSSigma-AldrichL2630
MIP1-α PE AntibodyBD Pharmingen554730Acute toxicity, oral
MonensinSigma-AldrichM5273
NaClSigma-AldrichS7653
NicotineSigma-AldrichN3876Acute toxicity, environmental hazard
ParafilmBemis“M”
ParaformaldehydeSigma-AldrichP6148Flammable, skin irritation
Pen/strepGibco Life Technologies15140-122
RPMI 1640Gibco Life Technologies11875-093
Running bufferMACS Running Buffer, Miltenyi Biotech130-091-221
Th1/Th2 CBA KitBD Biosciences551809
TNF-α Alexa Fluor 488 AntibodyBioLegend502915
Transfer pipetteFisher Scientific13-711-20
Tris BaseSigma-AldrichT1503

References

  1. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease, A Report of the Surgeon General. , U.S. Department of Health and Human Services. (2010).
  2. Zeller, M., Hatsukami, D. The Strategic Dialogu....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Tobacco Product PreparationPeripheral Blood Mononuclear CellsCytokine SecretionTarget Cell KillingFlow CytometryWhole Smoke Conditioned MediumK562 Cell Killing AssayIntracellular StainingCFSE LabelingLPS Stimulation